The UK drug regulator is reviewing the Ranbaxy Labs regulatory issues in the light of recent revelations to see whether the situation warrants any future action. Taking a cue from the US Department of Justice, UK drug regulator Medicines and Healthcare products Regulatory Agency (MHRA) has said it is reviewing the Ranbaxy Labs regulatory issues in the light of recent revelation to see whether the situation warrants any future action. The drug regulator is currently in discussion with the US Food and Drug Administration, other EU and global regulators for the same. 

Source: http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/uk-drug-regulator-reviewing-ranbaxys-regulatory-issues/articleshow/20826227.cms